Skip to content
Oncosil Medical
Main menu
  • Logo on scroll
  • Home
  • About
    • Company History
    • Leadership Team
    • Our Board
  • Research & Technology
    • Overview
    • Chemotherapy & OncoSil™
    • Indications
    • OncoSil™ Implant
    • Implant Aftercare
    • Radiation Safety Aspects
    • About Clinical Trials
    • Clinical Studies
    • Becoming an OncoSil™ Trial Centre
    • Important Risk Information
    • FAQ
  • Investor Centre
    • Overview
    • ASX Announcements
    • Analyst Reports
    • Annual Reports
    • Events & Presentations
    • Subscribe to Updates
    • Corporate Governance
  • Media Coverage
  • Contact Us

Medical Investment Opportunities -
Cancer Research: Overview

Welcome to the OncoSil Medical Ltd Investor Centre.

OncoSil Medical Ltd is a publicly traded biotechnology company listed on the Australian stock exchange (ASX: OSL). OncoSil is focused on delivering innovative interventional oncology therapies for patients with pancreatic cancer and liver cancer.

OncoSil has achieved significant progress meeting major milestones in 2016 and 2017.

Get in touch

OncoSil Medical Ltd,
Suite 402, Level 4 50 Berry Street,
North Sydney, NSW 2060
+61 2 9223 3344
info@oncosil.com.au
Follow us on Twitter
Follow us on LinkedIn
Footer
  • Disclaimer
  • Copyright ©2019 Oncosil Medical Ltd
  • Designed & Powered by Web Force 5